237 related articles for article (PubMed ID: 26553068)
1. Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions.
Lee JG; Shin JH; Shim HS; Lee CY; Kim DJ; Kim YS; Chung KY
Respir Res; 2015 Nov; 16():138. PubMed ID: 26553068
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells.
Chen J; Zhang L; Zhou H; Wang W; Luo Y; Yang H; Yi H
Mol Med Rep; 2018 May; 17(5):6859-6865. PubMed ID: 29512762
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
4. MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.
Cimas FJ; Callejas-Valera JL; Pascual-Serra R; García-Cano J; Garcia-Gil E; De la Cruz-Morcillo MA; Ortega-Muelas M; Serrano-Oviedo L; Gutkind JS; Sánchez-Prieto R
Oncotarget; 2015 Dec; 6(42):44095-107. PubMed ID: 26689986
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
Hao C; Liu G; Tian G
Ther Adv Respir Dis; 2019; 13():1753466619866097. PubMed ID: 31368411
[TBL] [Abstract][Full Text] [Related]
6. Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.
Wang BS; Liu YZ; Yang Y; Zhang Y; Hao JJ; Yang H; Wang XM; Zhang ZQ; Zhan QM; Wang MR
Clin Sci (Lond); 2013 Feb; 124(3):203-14. PubMed ID: 22963397
[TBL] [Abstract][Full Text] [Related]
7. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy.
Ren JH; He WS; Nong L; Zhu QY; Hu K; Zhang RG; Huang LL; Zhu F; Wu G
Cancer Biother Radiopharm; 2010 Feb; 25(1):75-80. PubMed ID: 20187799
[TBL] [Abstract][Full Text] [Related]
8. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
[TBL] [Abstract][Full Text] [Related]
10. Bu-Zhong-Yi-Qi Decoction, the Water Extract of Chinese Traditional Herbal Medicine, Enhances Cisplatin Cytotoxicity in A549/DDP Cells through Induction of Apoptosis and Autophagy.
Yu N; Xiong Y; Wang C
Biomed Res Int; 2017; 2017():3692797. PubMed ID: 28154825
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell.
Li N; Li X; Li S; Zhou S; Zhou Q
Biochem Biophys Res Commun; 2013 Sep; 439(2):187-90. PubMed ID: 23994634
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.
Wu HM; Jiang ZF; Ding PS; Shao LJ; Liu RY
Sci Rep; 2015 Jul; 5():12291. PubMed ID: 26201611
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine Feiyanning cooperates with cisplatin to enhance cytotoxicity to non-small-cell lung cancer by inhibiting protective autophagy.
Zheng Z; Ma Y; Wang L; Deng H; Wang Z; Li J; Xu Z
J Ethnopharmacol; 2021 Aug; 276():114196. PubMed ID: 33984457
[TBL] [Abstract][Full Text] [Related]
14. Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells.
Pradhan S; Mahajan D; Kaur P; Pandey N; Sharma C; Srivastava T
Oncotarget; 2016 Nov; 7(44):71841-71855. PubMed ID: 27708247
[TBL] [Abstract][Full Text] [Related]
15. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
16. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
17. A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.
Sharma K; Goehe RW; Di X; Hicks MA; Torti SV; Torti FM; Harada H; Gewirtz DA
Autophagy; 2014; 10(12):2346-61. PubMed ID: 25629933
[TBL] [Abstract][Full Text] [Related]
18. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells.
Patel NH; Xu J; Saleh T; Wu Y; Lima S; Gewirtz DA
Biochem Pharmacol; 2020 May; 175():113896. PubMed ID: 32135156
[TBL] [Abstract][Full Text] [Related]
19. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
García-Cano J; Ambroise G; Pascual-Serra R; Carrión MC; Serrano-Oviedo L; Ortega-Muelas M; Cimas FJ; Sabater S; Ruiz-Hidalgo MJ; Sanchez Perez I; Mas A; Jalón FA; Vazquez A; Sánchez-Prieto R
Oncotarget; 2015 Jun; 6(17):15551-65. PubMed ID: 26036632
[TBL] [Abstract][Full Text] [Related]
20. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
